期刊文献+

血液透析患者促红素敏感性与胰岛素抵抗相关性研究 被引量:3

Relationship between insulin resistance and erythropoietin sensitivity in patients with maintenance hemodialysis
下载PDF
导出
摘要 目的探讨维持血液透析(MHD)患者促红素敏感性与胰岛素抵抗的相关性。方法检测12例糖尿病肾病MHD患者、66例非糖尿病肾病MHD患者及12例健康对照者临床及生化指标,以rHuEPO用量/Hb比值(rHuEPO/Hb)作为促红素反应性指标、计算胰岛素抵抗指数(HOMA-IR)。结果糖尿病肾病组及非糖尿肾病组均存在促红素低反应,分别为56.6%和32.4%,糖尿病肾病组维持血液透析患者甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白(LDL)、甲状旁腺激素(iPTH)、脂蛋白a(Lpa)、超敏C-反应蛋白(hs-CRP)、HOMA-IR均较非糖尿病肾病组及正常组增高(P<0.05),糖尿病肾病组增高更为明显,此外糖尿病肾病组血清白蛋白下降更为明显(P<0.05);相关分析提示rHuEPO/Hb比值与Alb(r=-0.166,P<0.05)、HDL(r=-0.233,P<0.05)呈负相关,与iPTH(r=0.382,P<0.05)、TG(r=0.258,P<0.05)、hs-CRP(r=0.399,P<0.05)和HOMA-IR(r=0.416,P<0.05)呈正相关,进一步行偏相关分析,结果示rHuEPO/Hb与HOMA-IR呈正相关(r=0.461,P<0.05)。结论维持血液透析患者促红素反应性与胰岛素抵抗密切相关。 Objective To investigate the relevance between erythropoietin sensitivity and insulin resistance in patients with maintenance hemodialysis.Methods The clinical and laboratory data were measured in 12 patients with diabetic nephropathy(group A) and 66 patients without diabetic nephropathy(group B) as well as 12 healthy individuals(the control group).The insulin resistance index(HOMA-IR) was calculated by erthropoietin response index,which regarded as the ratio of the dosage of rHuEPO and Hb.Results Erythropoietin hyporesponsiveness occurred both in group A and group B,and the erthropoietin response indexes were 56.6% and 32.4%,respectively.Patients in group A and group B had significantly higher serum triglyceride(TG),total cholesterol(TC),low density lipoprotein(LDL),parathyroid hormone(PTH),lipoprotein a(Lpa),high-sensitivity C-reactive protein(hs-CRP),and HOMA-IR(P0.05) but significantly lower serum albumin(P0.05) than the control group.The changes in group A were more profound.There was a significant negative correlation between(rHuEPO/Hb) ratio and serum albumin(r=-0.166,P0.05),high-density lipoprotein(r=-0.233,P0.05),and a significant positive correlation between(rHuEPO/Hb) ratio and parathyroid hormone(r=0.382,P0.05),high-sensitivity C-reactive protein(r= 0.258,P0.05),and HOMA-IR(r=0.416,P0.05) in the two groups.There was a significant independent positive correlation between(rHuEPO/Hb) ratio and HOMA-IR(r=0.461,P0.05).Conclusion Insulin resistance is associated with erythropoietin responsiveness in patients with maintenance hemodialysis.
出处 《海南医学》 CAS 2012年第2期3-6,共4页 Hainan Medical Journal
关键词 血液透析 肾性贫血 促红细胞生成素 胰岛素抵抗 Hemodialysis Renal anemia Erythropoietin Insulin resistance
  • 相关文献

参考文献20

  • 1Cameron JS. European best practice guidelines for the management of anaemia in patients with chronic renal failure [J]. Nephrol Dial Transplant, 1999, 14(Suppl 2): 61-65.
  • 2Mlinar B, Marc J, J anez A, et al. Molecular mechanisms of insulin resistance and associated diseases [J]. Clin Chim Acta, 2007, 375 (1-2): 20-35.
  • 3Peralta CA, Kurella M, Lo JC, et al. The metabolic syndrome and chronic kidney disease [J]. Curr Opin Nephrol Hypertens, 2006, 15: 361-365.
  • 4Abe M, Okada K, Soma M, et al. Relationship between insulin resis- tance and erythropoietin responsiveness in hemodialysis patients [J]. Clin Nephrol, 2011, 75(1): 49-58.
  • 5Mc Gill JB, Bell DS. Anemia and the role of erythropoietin in diabe- tes [J]. J Diabetes Complications, 2006, 20: 262- 272.
  • 6AI Khoury S, Afzali B, Shah N, et al. Anaemia in diabetic patients with chronic kidney diseases prevalence and predietors [J]. Diabeto- logia, 2006, 49: 1183-1189.
  • 7Ritz E. Anemia and diabetic nephropathy [J]. Curt Diab Rep, 2006, 6: 469-472.
  • 8Mojiminiyi OA, Abdella NA, Zaki MY, et al. Prevalence and associ- ations of low plasma erythropoietin in patients with type 2 diabetes mellitus [J]. Diabet Med, 2006, 23: 839- 844.
  • 9Lorber D, Reddan D. Clinical characteristics of chronic kidney dis- ease patients with and without diabetes: a subanalysis of the PAERI study [J]. Clin Nephrol, 2006, 66: 11-16.
  • 10Thomas MC, Cooper ,ME, Rossing K, et al. Anaemia in diabetes: Is there a rationale to TREAT? [J]. Diabct Ologia, 2006, 49:1151-1157.

二级参考文献2

  • 1王海燕.肾性贫血.肾脏病学(第2版)[M].北京:人民卫生出版社,1997.1396.
  • 2叶任高 沈清瑞.慢性肾功能衰竭.肾脏病诊断与治疗学(第1版)[M].北京:人民卫生出版社,1996.549.

共引文献45

同被引文献51

  • 1Gesualdo L, Combe C, CovicA, et al. Risk-based individualisation of target hemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes voraus actual pract/ce patterns (MONITOR-CKD5 study) [J]. Int Urol Nephrol, 2015, 47 (5): 837-845.
  • 2Kaze FF, Kengne AP, MambapAT, ctal. Anemia in palients on chronic hemodialysis in Cameroon: prevalence, characteristics and management in low resources setting [J]. Afr Health Sei, 2015, 15 (1): 253-260.
  • 3Wiqcck A, Piecha G. Is haemodiafiltration more favourable thanhaemodialysis for treatment of renal anaemia7 [J]. Nephrol D/al Transplant, 2015, 30(4): 523-525.
  • 4Czifra A, P~l A, Sebesty~a V, et al. End stage renal disease and ven- tr/cular arrhythmia. Hemodialysis and hemocliafiltration differently affect ventricular repolarizafion [J]. Orv Hetil, 2015, 156(12): 463-471.
  • 5Kudoh Y, Aoyama S, Torii T, et al. Long-term effects of oral L-carni- fine supplementation on anemia in chronic hemodialysis [J]. Cardio- renal Med, 2014, 4(1): 53-59.
  • 6Murphy WJ, Steiber A, Connery G-C, et ai. Altered carnitine metabo- lism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation [J]. Nephrol Dial Transplant, 2012, 27(1): 304-310.
  • 7Macdougall IC, S~auss WE, McLaugldin J, et al. A randomized comparison of ferumoxytol and iron sucrose for ~ating iron deft- ciency anemia in patients with CKD[J]. Clin J Am Soc Nvphrol, 2014, 9(4): 705-712.
  • 8Onken J-E, Bregman DB, Harrington RA, et al. Ferric carboxymalt- ose in patients with iron-deficiency anvmia and impaired tonal func- tion: the REPAIR-IDA trial [J]. Nephrol Dial Transplant, 2014, 29 (4): 833-842.
  • 9Goldstein SL, Morris D, Warady BA. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, ad- olescents, and young adults with CKD: a randomized controlled tri- al [J]. Am J Kidney Dis, 2013, 61(4): 588-597.
  • 10Wilson PD, Hutchings A, Jeans A, et al. An analysis of the health service efficiency and patient experience with two different intrave- nous iron preparations in a UK anaemia clinic [J]. J Med Econ, 2013, 16(1): 108-114.

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部